Drug Information

Drug General Information
Drug ID
D0I9AR
Former ID
DIB012069
Drug Name
BMS-185857
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Terminated [545818]
Company
Bristol-Myers Squibb AG
Target and Pathway
Target(s) Protein farnesyltransferase beta subunit Target Info Modulator [550890]
KEGG Pathway Terpenoid backbone biosynthesis
Biosynthesis of antibiotics
NetPath Pathway TSH Signaling Pathway
Reactome Inactivation, recovery and regulation of the phototransduction cascade
WikiPathways Visual phototransduction
References
Ref 545818Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004901)
Ref 550890US patent application no. 2005,0227,929, Combination therapy comprising a cox-2 inhibitor and an antineoplastic agent.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.